Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone

Robert Rapaport, James Oleske, Houman Ahdieh, Sally Cohen, Carol Delfaus, Thomas Denny

Research output: Contribution to journalArticle

Abstract

Inasmuch as growth hormone is known to interact with the immune system, we studied immune functions including immunoglobulins, cell surface markers, mitogen responses, and polymorphonuclear cell function in eight children with growth hormone deficiency, ages 1 to 17 years, before and during treatment with human growth hormone for 12 to 16 months. Before treatment, immune functions were normal in all children. Treatment with human growth hormone did not significantly affect serum immunoglobulins, polymorphonuclear cell function, or percent T cells. However, percent B cells decreased to subnormal levels in seven of seven patients. T helper/suppressor ratios, decreased in all patients, to subnormal values in seven of eight patients; and mitogen responses decreased to below normal in all. The decline of percent B cells was transient in all patients, of T helper/suppressor ratios in seven of eight, and mitogen responses in five of eight patients. In vitro incubation of lymphocytes with growth hormone resulted in no changes in cell surface markers or mitogen responses. Although the depression of immune functions resulted in no increased rate of infections during the observation period, we do not know the possible effects of prolonged treatment and therefore caution, against the indiscriminate use of human growth hormone. The effects of biosynthetically obtained growth hormone on immune function remain to be determined.

Original languageEnglish (US)
Pages (from-to)434-439
Number of pages6
JournalThe Journal of Pediatrics
Volume109
Issue number3
DOIs
StatePublished - 1986

Fingerprint

Human Growth Hormone
Growth Hormone
Mitogens
B-Lymphocytes
Therapeutics
B-Cell Antigen Receptors
Immunoglobulins
Immune System
Observation
Lymphocytes
T-Lymphocytes
Infection
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone. / Rapaport, Robert; Oleske, James; Ahdieh, Houman; Cohen, Sally; Delfaus, Carol; Denny, Thomas.

In: The Journal of Pediatrics, Vol. 109, No. 3, 1986, p. 434-439.

Research output: Contribution to journalArticle

Rapaport, Robert ; Oleske, James ; Ahdieh, Houman ; Cohen, Sally ; Delfaus, Carol ; Denny, Thomas. / Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone. In: The Journal of Pediatrics. 1986 ; Vol. 109, No. 3. pp. 434-439.
@article{f4e4453085e54150afcb84ca09c7daec,
title = "Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone",
abstract = "Inasmuch as growth hormone is known to interact with the immune system, we studied immune functions including immunoglobulins, cell surface markers, mitogen responses, and polymorphonuclear cell function in eight children with growth hormone deficiency, ages 1 to 17 years, before and during treatment with human growth hormone for 12 to 16 months. Before treatment, immune functions were normal in all children. Treatment with human growth hormone did not significantly affect serum immunoglobulins, polymorphonuclear cell function, or percent T cells. However, percent B cells decreased to subnormal levels in seven of seven patients. T helper/suppressor ratios, decreased in all patients, to subnormal values in seven of eight patients; and mitogen responses decreased to below normal in all. The decline of percent B cells was transient in all patients, of T helper/suppressor ratios in seven of eight, and mitogen responses in five of eight patients. In vitro incubation of lymphocytes with growth hormone resulted in no changes in cell surface markers or mitogen responses. Although the depression of immune functions resulted in no increased rate of infections during the observation period, we do not know the possible effects of prolonged treatment and therefore caution, against the indiscriminate use of human growth hormone. The effects of biosynthetically obtained growth hormone on immune function remain to be determined.",
author = "Robert Rapaport and James Oleske and Houman Ahdieh and Sally Cohen and Carol Delfaus and Thomas Denny",
year = "1986",
doi = "10.1016/S0022-3476(86)80113-5",
language = "English (US)",
volume = "109",
pages = "434--439",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone

AU - Rapaport, Robert

AU - Oleske, James

AU - Ahdieh, Houman

AU - Cohen, Sally

AU - Delfaus, Carol

AU - Denny, Thomas

PY - 1986

Y1 - 1986

N2 - Inasmuch as growth hormone is known to interact with the immune system, we studied immune functions including immunoglobulins, cell surface markers, mitogen responses, and polymorphonuclear cell function in eight children with growth hormone deficiency, ages 1 to 17 years, before and during treatment with human growth hormone for 12 to 16 months. Before treatment, immune functions were normal in all children. Treatment with human growth hormone did not significantly affect serum immunoglobulins, polymorphonuclear cell function, or percent T cells. However, percent B cells decreased to subnormal levels in seven of seven patients. T helper/suppressor ratios, decreased in all patients, to subnormal values in seven of eight patients; and mitogen responses decreased to below normal in all. The decline of percent B cells was transient in all patients, of T helper/suppressor ratios in seven of eight, and mitogen responses in five of eight patients. In vitro incubation of lymphocytes with growth hormone resulted in no changes in cell surface markers or mitogen responses. Although the depression of immune functions resulted in no increased rate of infections during the observation period, we do not know the possible effects of prolonged treatment and therefore caution, against the indiscriminate use of human growth hormone. The effects of biosynthetically obtained growth hormone on immune function remain to be determined.

AB - Inasmuch as growth hormone is known to interact with the immune system, we studied immune functions including immunoglobulins, cell surface markers, mitogen responses, and polymorphonuclear cell function in eight children with growth hormone deficiency, ages 1 to 17 years, before and during treatment with human growth hormone for 12 to 16 months. Before treatment, immune functions were normal in all children. Treatment with human growth hormone did not significantly affect serum immunoglobulins, polymorphonuclear cell function, or percent T cells. However, percent B cells decreased to subnormal levels in seven of seven patients. T helper/suppressor ratios, decreased in all patients, to subnormal values in seven of eight patients; and mitogen responses decreased to below normal in all. The decline of percent B cells was transient in all patients, of T helper/suppressor ratios in seven of eight, and mitogen responses in five of eight patients. In vitro incubation of lymphocytes with growth hormone resulted in no changes in cell surface markers or mitogen responses. Although the depression of immune functions resulted in no increased rate of infections during the observation period, we do not know the possible effects of prolonged treatment and therefore caution, against the indiscriminate use of human growth hormone. The effects of biosynthetically obtained growth hormone on immune function remain to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0022540012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022540012&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(86)80113-5

DO - 10.1016/S0022-3476(86)80113-5

M3 - Article

VL - 109

SP - 434

EP - 439

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -